Intensive Blood Pressure Control May Delay Progression in Advanced CKD
Patients with advanced CKD have not been well-represented in trials evaluating intensive blood pressure control.
All articles by Natasha Persaud
Nonsteroidal MRAs Reduce Kidney, Cardiovascular Risks
The systematic review and meta-analysis included a broad range of patients with and without chronic kidney disease.
Comparable Adverse Effects Seen for HIF-PHIs and ESAs
Investigators report results from a systematic review and meta-analysis of data from 23 randomized controlled trials involving 15,144 patients with anemia of CKD.
Efficacy of NMIBC Treatments After BCG Failure Characterized
A systematic review evaluated current and investigational intravesical and systemic therapies for NMIBC after BCG failure, including chemotherapy, immunotherapy, combination therapy, hyperthermia, and novel biologic agents.
Hepatitis C Guideline Updated for Chronic Kidney Disease Population
The update reflects advances in hepatitis C management, such as antiviral therapy, increased use of hepatitis C kidney grafts, and treatment of glomerular diseases associated with the virus.
Resistant Hypertension Effectively Treated With Novel Drug
Blocking the endothelin pathway could represent a new mode of action to lower blood pressure in resistant hypertension, according to investigators.
Efpeglenatide Improves Renal, Cardiovascular Outcomes in High-Risk Diabetes
Among the patients with high-risk diabetes in the trial, 21.8% had both a history of cardiovascular disease and current kidney disease.
Trimethoprim-Sulfamethoxazole vs Amoxicillin Ups Hyperkalemia Risk
Trimethoprim-sulfamethoxazole is mostly excreted through the kidneys, and it can cause hyperkalemia by reducing potassium excretion.
In Advanced Prostate Cancer, Statin Use With Androgen Ablation Ups Survival
Statin use in prostate cancer is attractive given their proven cardiovascular benefits and favorable toxicity profile, according to investigators.
Lupus Nephritis Drug Voclosporin Shows Efficacy, Safety Over 3 Years
One study focused on patients with severe lupus nephritis, who are at greatest risk for kidney failure.
